top of page

Sat, Oct 01

|

Online Event

Transplant Oncology: Immuno-Oncology for Transplant Patients

Solid organ transplant recipients are at 3-10 times higher risk of cancer compared to non-transplant patients, due to long-standing immunosuppression. Cancer immunotherapy has become a standard therapy for many cancers, but its use in transplant patients is challenging because of safety and efficacy

Registration is closed
See other events
Transplant Oncology: Immuno-Oncology for Transplant Patients
Transplant Oncology: Immuno-Oncology for Transplant Patients

Time & Location

Oct 01, 2022, 9:00 AM – 12:05 PM EDT

Online Event

Share this event

bottom of page